$57.4 M

TCON Mkt cap, 14-Sept-2021
TRACON Pharmaceuticals Net income (FY, 2020)-16.8 M
TRACON Pharmaceuticals EBIT (FY, 2020)-16.2 M
TRACON Pharmaceuticals Cash, 31-Dec-202032.1 M
TRACON Pharmaceuticals EV35.6 M
Get notified regarding key financial metrics and revenue changes at TRACON PharmaceuticalsLearn more
Banner background

TRACON Pharmaceuticals Balance Sheet

Annual

USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

41.4m35.7m29.5m25.1m16.4m32.1m

Accounts Receivable

9.4m

Prepaid Expenses

1.6m1.5m848.0k784.0k

Inventories

8.0m

Current Assets

53.3m45.6m36.1m40.6m17.3m36.9m

PP&E

173.0k82.0k73.0k45.0k23.0k16.0k

Total Assets

53.5m45.7m36.1m40.6m18.1m37.4m

Accounts Payable

8.3m6.2m1.7m

Short-term debt

2.8m1.1m2.6m9.0m

Current Liabilities

14.2m10.2m11.8m13.5m11.8m10.5m

Long-term debt

4.6m5.3m2.7m1.4m

Total Debt

7.4m6.4m5.3m10.3m

Common Stock

18.0k30.0k4.0k15.0k

Additional Paid-in Capital

89.6m113.9m121.7m161.1m165.0m204.2m

Retained Earnings

(58.6m)(85.6m)(104.7m)(139.7m)(162.3m)(179.1m)

Total Equity

31.0m28.3m17.0m21.4m2.7m25.1m

Financial Leverage

1.7 x1.6 x2.1 x1.9 x6.7 x1.5 x

Quarterly

USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

65.3m61.2m47.2m43.3m34.0m29.6m32.2m26.0m32.9m62.5m34.4m28.2m22.1m26.3m19.1m14.1m14.5m

Prepaid Expenses

1.7m4.3m2.2m1.3m1.6m1.4m1.1m814.0k1.4m1.3m1.5m1.3m1.0m594.0k1.2m835.0k503.0k

Current Assets

67.0m65.5m59.9m46.8m37.7m36.5m37.8m32.8m37.3m63.8m54.9m48.4m33.1m26.9m20.3m15.0m15.0m

PP&E

91.0k143.0k141.0k152.0k128.0k106.0k75.0k78.0k71.0k66.0k59.0k52.0k38.0k32.0k27.0k19.0k16.0k

Total Assets

67.1m65.7m60.0m47.0m37.9m36.6m37.9m32.9m37.4m63.9m54.9m48.5m34.2m28.0m21.2m15.7m15.7m

Accounts Payable

3.5m6.1m7.0m

Short-term debt

4.7m321.0k2.4m3.5m3.5m343.0k1.2m2.0m533.0k370.0k1.8m2.5m2.6m1.3m1.7m

Current Liabilities

12.8m10.9m11.6m14.2m13.2m13.2m7.8m9.2m9.8m15.1m11.3m13.6m13.6m13.9m12.8m8.8m9.2m

Long-term debt

3.0m6.8m6.6m16.6m15.7m4.8m6.7m6.0m5.3m6.2m6.3m6.0m4.7m4.1m3.4m3.4m2.8m

Total Debt

7.8m6.8m6.9m19.0m19.2m8.3m7.1m7.2m7.3m6.7m6.3m6.3m6.5m6.6m6.0m4.7m4.5m

Common Stock

12.0k12.0k12.0k12.0k12.0k13.0k17.0k17.0k17.0k28.0k30.0k30.0k30.0k30.0k30.0k5.0k8.0k

Additional Paid-in Capital

87.3m87.9m88.6m90.4m91.5m97.1m115.7m116.6m119.9m155.5m159.7m160.4m161.6m162.1m162.4m169.1m173.8m

Retained Earnings

(38.2m)(41.1m)(47.5m)(65.1m)(73.4m)(79.3m)(92.7m)(99.3m)(98.1m)(113.1m)(122.8m)(131.9m)(146.9m)(153.2m)(158.4m)(166.4m)(170.8m)

Total Equity

49.2m46.8m41.1m25.3m18.1m17.8m23.0m17.3m21.8m42.5m37.0m28.6m14.8m8.9m4.0m2.8m3.0m

Financial Leverage

1.4 x1.4 x1.5 x1.9 x2.1 x2.1 x1.6 x1.9 x1.7 x1.5 x1.5 x1.7 x2.3 x3.1 x5.3 x5.7 x5.2 x

TRACON Pharmaceuticals Cash Flow

Annual

USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(24.4m)(27.0m)(19.1m)(35.0m)(22.7m)(16.8m)

Depreciation and Amortization

94.0k48.0k28.0k22.0k12.0k

Accounts Payable

(2.2m)

Cash From Operating Activities

(27.1m)(13.2m)(30.8m)(23.6m)(17.0m)

Purchases of PP&E

(3.0k)(39.0k)(5.0k)

Cash From Investing Activities

2.1m3.7m(8.9m)14.0m(4.0m)

Long-term Borrowings

(2.0m)(8.8m)(8.3m)(1.4m)(1.4m)

Cash From Financing Activities

19.4m3.3m35.3m906.0k36.8m

Net Change in Cash

(6.2m)(4.3m)(8.7m)15.7m

Interest Paid

622.0k664.0k642.0k612.0k443.0k

TRACON Pharmaceuticals Ratios

USDQ1, 2015

Financial Leverage

1.4 x